Exposure of chronic obstructive pulmonary disease patients to particles: Respiratory and cardiovascular health effects

被引:0
|
作者
MICHAEL BRAUER
STEFANIE T EBELT
TERI V FISHER
JOCHEN BRUMM
A JOHN PETKAU
SVERRE VEDAL
机构
[1] School of Occupational and Environmental Hygiene,Department of Medicine
[2] The University of British Columbia,Department of Statistics
[3] The University of British Columbia,undefined
[4] The University of British Columbia,undefined
关键词
air pollution; environmental exposure; heart rate; heart rate variability; lung function; particles;
D O I
暂无
中图分类号
学科分类号
摘要
To examine hypotheses regarding air pollution health effects, we conducted an exploratory study to evaluate relationships between personal and ambient concentrations of particles with measures of cardiopulmonary health in a sample of patients with chronic obstructive pulmonary disease (COPD). Sixteen currently non-smoking COPD patients (mean age=74) residing in Vancouver were equipped with a particle (PM2.5) monitor for seven 24-h periods. Subjects underwent ambulatory heart monitoring, had their lung function and blood pressure (BP) measured, and recorded symptoms and medication use. Ambient PM2.5, PM10, sulfate, and gaseous pollutant concentrations were monitored at five sites within the study area. Although no associations between air pollution and lung function were statistically significant, an estimated effect of 3% and 1% declines in daily FEV1 change (ΔFEV1) for each 10 μg/m3 increase in ambient PM10 and PM2.5, respectively, was observed. Increases of 1 μg/m3 in personal or ambient sulfate were associated with 1.0% and 0.3% declines in ΔFEV1, respectively. Weak associations were observed between particle concentrations and increased supraventricular ectopic heartbeats and with decreased systolic BP. No consistent associations were observed between any particle metric and diastolic BP, heart rate, or heart rate variability (r-MSSD or SDNN), symptom severity, or bronchodilator use. Of the pollutants measured, ambient PM10 was most consistently associated with health parameters; the use of personal exposures did not improve the strength of any associations or lead to increased effect estimates.
引用
收藏
页码:490 / 500
页数:10
相关论文
共 50 条
  • [21] Cardiovascular disease in patients with chronic obstructive pulmonary disease, Saskatchewan Canada cardiovascular disease in COPD patients
    Curkendall, SM
    DeLuise, C
    Jones, JK
    Lanes, S
    Stang, MR
    Goehring, E
    She, DW
    ANNALS OF EPIDEMIOLOGY, 2006, 16 (01) : 63 - 70
  • [22] Management of Chronic Obstructive Pulmonary Disease in Patients with Cardiovascular Diseases
    Mario Cazzola
    Luigino Calzetta
    Barbara Rinaldi
    Clive Page
    Giuseppe Rosano
    Paola Rogliani
    Maria Gabriella Matera
    Drugs, 2017, 77 : 721 - 732
  • [23] Management of cardiovascular comorbidities in chronic obstructive pulmonary disease patients
    Aisanov, Zaurbek
    Khaltaev, Nikolai
    JOURNAL OF THORACIC DISEASE, 2020, 12 (05) : 2791 - 2802
  • [24] Pleiotropic Effects of Rosuvastatin in Chronic Obstructive Pulmonary Disease Patients With High Cardiovascular Risk
    Samorukova, E. I.
    Adasheva, T. V.
    Zadionchenko, V. S.
    Rosliakova, G. A.
    KARDIOLOGIYA, 2015, 55 (07) : 32 - 37
  • [25] Effect of respiratory rate on respiratory patterns in patients with chronic obstructive pulmonary disease
    Inoue, M
    Homma, T
    Aoki, H
    Sumi, M
    Ohtsu, I
    Tomioka, S
    Hagiya, M
    Yamashita, Y
    Hasegawa, S
    INTERNAL MEDICINE, 1997, 36 (11) : 771 - 775
  • [26] Longitudinal changes in health status using the Chronic Respiratory Disease Questionnaire and pulmonary function in patients with stable Chronic Obstructive Pulmonary Disease
    Oga, T
    Nishimura, K
    Tsukino, M
    Hajiro, T
    Sato, S
    Ikeda, A
    Hamada, C
    Mishima, M
    QUALITY OF LIFE RESEARCH, 2004, 13 (06) : 1109 - 1116
  • [27] Longitudinal Changes in Health Status Using the Chronic Respiratory Disease Questionnaire and Pulmonary Function in Patients with Stable Chronic Obstructive Pulmonary Disease
    T. Oga
    K. Nishimura
    M. Tsukino
    T. Hajiro
    S. Sato
    A. Ikeda
    C. Hamada
    M. Mishima
    Quality of Life Research, 2004, 13 : 1109 - 1116
  • [28] Experimental determination of the respiratory tract deposition of diesel combustion particles in patients with chronic obstructive pulmonary disease
    Londahl, Jakob
    Swietlicki, Erik
    Rissler, Jenny
    Bengtsson, Agneta
    Boman, Christoffer
    Blomberg, Anders
    Sandstrom, Thomas
    PARTICLE AND FIBRE TOXICOLOGY, 2012, 9
  • [29] Experimental determination of the respiratory tract deposition of diesel combustion particles in patients with chronic obstructive pulmonary disease
    Jakob Löndahl
    Erik Swietlicki
    Jenny Rissler
    Agneta Bengtsson
    Christoffer Boman
    Anders Blomberg
    Thomas Sandström
    Particle and Fibre Toxicology, 9
  • [30] β-Blocker and survival and pulmonary function in patients with chronic obstructive pulmonary and cardiovascular disease
    Tang, Hui
    Yang, Zu-Yao
    Tang, Jin-Ling
    EUROPEAN HEART JOURNAL, 2021, 42 (12) : 1180 - 1180